TerminatedNot applicableNCT01625923

A Pilot Study on the Efficacy and Safety of Olanzapine in Gastroparesis

Studying Idiopathic gastroparesis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Michigan
Principal Investigator
Allen Lee, MD
University of Michigan
Intervention
Olanzapine(drug)
Enrollment
3 target
Eligibility
18-70 years · All sexes
Timeline
20132019

Study locations (2)

Collaborators

Massachusetts General Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01625923 on ClinicalTrials.gov

Other trials for Idiopathic gastroparesis

Additional recruiting or active studies for the same condition.

See all trials for Idiopathic gastroparesis

← Back to all trials